Literature DB >> 34962115

Are the Current Guidelines Sufficient to Establish Infection Control Strategies for COVID-19 Related Issues in Hospitals?

Wooyoung Jang1, Bongyoung Kim2, Eu Suk Kim3, Kyoung-Ho Song3, Song Mi Moon4, Myung Jin Lee5, Ji Young Park6, Ji-Yeon Kim7, Myoung Jin Shin8, Hyunju Lee9, Hong Bin Kim10.   

Abstract

As hospitals cater to elderly and vulnerable patients, a high mortality rate is expected if a coronavirus disease 2019 (COVID-19) outbreak occurs. Consequently, policies to prevent the spread of COVID-19 in hospital settings are essential. This study was conducted to investigate how effectively national and international guidelines provide recommendations for infection control issues in hospitals. After selecting important issues in infection control, we performed a systematic review and analysis of recommendations and guidelines for preventing COVID-19 transmission within medical institutions at national and international levels. We analyzed guidelines from the World Health Organization, Centers for Disease Control and Prevention, European Centre for Disease Prevention and Control, and Korea Disease Control and Prevention Agency. Recent guidelines do not provide specific solutions to infection control issues. Therefore, efforts need to be made to devise consistent advice and guidelines for COVID-19 control.
© 2021 The Korean Academy of Medical Sciences.

Entities:  

Keywords:  Coronavirus Disease 2019; Guidelines; Hospital; Infection Control

Mesh:

Year:  2021        PMID: 34962115      PMCID: PMC8728589          DOI: 10.3346/jkms.2021.36.e343

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


INTRODUCTION

As hospitals are where elderly patients and those with underlying comorbidities are mainly cared for, a high mortality rate is expected if a coronavirus disease 2019 (COVID-19) outbreak occurs in hospitals. Therefore, strict measures to prevent the spread of COVID-19 in hospital settings are crucial. There are some guidelines to prevent the spread of COVID-19 in hospitals at the national and international levels.1234567891011121314151617 This study aimed to review whether national and international guidelines provide detailed recommendations to tackle issues with infection control and prevent the spread of COVID-19 in hospitals.

METHODS

We performed a systematic search for controversial issues regarding infection control during the management of patients with COVID-19 in the hospital. Controversial issues and key questions were selected based on discussions with four infectious diseases specialists (B.K., E.S.K., K.H.S., and H.B.K.). The selected issues and subordinate questions are listed in Supplementary Table 1. For the review of domestic and international guidelines, official websites of the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), European Centre for Disease Prevention and Control (ECDC), and Korea Disease Control and Prevention Agency (KDCA) were screened. Guidelines issued between January 1, 2020, and September 30, 2020, were investigated independently by two researchers (W.J. and B.K.), and contents relevant to the selected issues and subordinate questions were extracted (Supplementary Fig. 1). The reviewed guidelines and their official websites are presented in Supplementary Table 2. The contents were rephrased based on consensus among investigators (W.J. B.K., E.S.K., K.H.S., and H.B.K.).

Ethics statement

The study protocol was approved by the Institutional Review Board of the Seoul National University Bundang Hospital (B-2101/660-303). All methods were performed in accordance with these guidelines and regulations.

RESULTS

Infection control measures for the management of COVID-19 patients

As for screening and selective treatment policies, most organizations recommended that patients with COVID-19 symptoms should be treated at a screening clinic. However, no organization provided recommendations for the type of screening that should be used to identify patients who need to visit a screening clinic, nor did any organization specify criteria for permission to enter the general outpatient clinic for patients with fever and/or respiratory symptoms. All organizations suggested educating patients and caregivers about wearing masks in the hospital. WHO, CDC, and KDCA recommended a single isolated room for preemptive isolation; however, no organization provided recommendations for determining a specific ward for preemptive isolation. Each organization suggested different criteria for removing preemptive isolation; the disappearance of symptoms was recommended by WHO, a single negative polymerase chain reaction (PCR) result was recommended by CDC, and there was no recommendation by KDCA. As for an isolation policy for patients with confirmed COVID-19, ECDC and KDCA recommended room requirements for isolation, while WHO and CDC had no recommendations. ECDC and KDCA recommended a single negative pressure room, but they recommended organizing a cohort isolation ward for COVID-19 patients in the case of a shortage of negative pressure rooms. All organizations recommended implementing the symptom-based criteria for removing confirmed COVID-19 patients from isolation. PCR tests, even for patients without symptoms of COVID-19, were recommended by CDC, while other organizations had no recommendations regarding diagnostic testing. In the case of emergency procedures or operations for patients with suspected COVID-19, CDC and KDCA recommended rapid PCR tests for determining the possibility of COVID-19. On the strategy for hospital care for healthy individuals who come in close contact with an individual in self-quarantine, only CDC suggested providing a preemptive isolation room for such persons. No organization had recommendations for patients who are released from isolation based on the improvement of symptoms but have consistently positive results from the PCR test (Table 1).
Table 1

Infection control measures for the management of COVID-19 patients

Controversial issues and subordinate questionsWHOCDCECDCKDCA
Screening and selective treatment policy to prevent COVID-19 patients from entering the hospital
1. System to prevent patients with COVID-19 symptoms from visiting places where other patientsTelemedicine screeningTelemedicine screeningTelemedicine screeningScreening symptoms using online-based survey
2. Criteria of patients treated at the screening clinicCOVID-19 symptomsCOVID-19 symptoms, epidemiologically relevant-COVID-19 symptoms, epidemiologically relevant, recent overseas travel
3. Screening measure for selecting of patients who need to visit the screening clinic----
4. Criteria for permission of entrance to the general outpatient clinic for patients with fever and/or respiratory symptoms----
5. Location of the screening clinic-Separated area from hospital buildingSeparated area from hospital buildingSeparated area from hospital building
6. Location of the sampling area-Separated area from hospital buildingSeparated area from hospital building, Areas for drive-through samplingSeparated area from hospital building, Areas for drive-through sampling
7. Isolation rooms in the emergency department for suspected or confirmed patients with COVID-19--RecommendRecommend
8. Education concerning wearing of masks for patients and caregivers in the hospitalRecommendRecommendRecommendRecommend
9. Regular monitoring of fever and respiratory symptoms of caregivers-Recommend--
10. Other measures to prevent the influx of COVID-19 into the hospital through caregivers and family/acquaintancesMandate to wear of masksRestrict visiting and recommend video callKeeping hand/respiratory hygiene, physical distancing, restrict visiting and recommend video callMandate to wear of masks
Preemptive isolation policy for patients with suspected COVID-19
1. Patients recommended for preemptive isolationCOVID-19 symptomsCOVID-19 symptoms, epidemiologically relevant-COVID-19 symptoms, epidemiologically relevant
2. Room for preemptive isolationSingle isolated roomSingle isolated room-Single isolated room
3. Ward for preemptive isolation----
4. Preemptive isolation strategy if the number of suspected patients exceeds the hospital's capacityGrouping patients by symptoms in the same place (with keeping physical distance each other)Isolate in general ward (with keeping physical distance each other)--
5. Criteria for removing preemptive isolationDisappearance of symptoms (regardless of PCR results)Single negative PCR result--
6. Measures for close family members and caregivers of suspected patients during preemptive isolation-Restrict entering hospital-Restrict entering hospital
Isolation policy for patients with confirmed COVID-19
1. Room for isolation of patients with COVID-19--Single room with negative pressureSingle room with negative pressure
2. Existence of separate isolation ward for patients with COVID-19--Organize cohort isolation ward if the number of patients exceeds the capacityOrganize cohort isolation ward if the number of patients exceeds the capacity
3. Type of isolation room in the case of shortage of negative pressure room due to the increase of patients with COVID-19--Single room without negative pressureSingle room without negative pressure
4. Designated routes that minimize contact with suspected or confirmed COVID-19 patients-Recommend-Recommend
5. Criteria for removing the isolation for confirmed COVID-19 patientsSymptom-based criteriaaSymptom-based criteriaaSymptom-based criteriaaSymptom-based criteriaa
PCR test for patients without symptoms of COVID-19
1. Range of performing PCR test for patients without symptoms and/or epidemiologically relevance of COVID-19-Prior to admission or surgical procedure in closed facility--
Strategy for procedures or operations for patients with suspected or confirmed COVID-19
1. Policy for detecting cases of COVID-19 infection before emergent procedures or operations-Recommend rapid PCR test-Recommend rapid PCR test
2. Decision-making process for operations or procedures in patients suspected of COVID-19 in an emergent situation----
3. Infection control policy in the operating room during the treatment of confirmed or suspected COVID-19 patientsPerform procedures in an adequately ventilated roomAvoid AGPEnvironmental disinfection using sodium hypochlorite after proceduresPerform procedures in an adequately ventilated room, environmental disinfection using sodium hypochlorite after procedures
Strategy for hospital care for close contacts during self-quarantine period
1. Allocation of rooms in case of hospitalization-Preemptive isolation room--
2. Elective procedures or operations policyPerform procedure after the self-quarantine period, but perform it wearing proper PPE in emergent situationPerform procedure after the self-quarantine period, but perform it wearing proper PPE in emergent situationPerform procedure after the self-quarantine period, but perform it wearing proper PPE in emergent situationPerform procedure after the self-quarantine period, but perform it wearing proper PPE in emergent situation
Strategy for hospital care for patients whose symptoms have improved and released from isolation but COVID-19 PCR results are still positive
1. Allocation of rooms in case of hospitalization----
2. Elective procedures or operations policy----

COVID-19 = coronavirus disease 2019, WHO = World Health Organization, CDC = Centers for Disease Control and Prevention, ECDC = European Centre for Disease Prevention and Control, KDCA = Korea Disease Control and Prevention Agency, PPE = personal protective equipment, PCR = polymerase chain reaction, AGP = aerosol-generating procedure.

aSymptom-based criteria for discontinuing transmission-based precautions; - Patients with mild to moderate illness who are not severely immunocompromised: (1) At least 10 days have passed since symptoms first appeared, (2) At least 24 hours have passed since last fever without the use of fever-reducing medications, and (3) Symptoms (e.g., cough, shortness of breath) have improved. - Patients with severe to critical illness or who are severely immunocompromised: (1) At least 10 days and up to 20 days have passed since symptoms first appeared, (2) At least 24 hours have passed since last fever without the use of fever-reducing medications, (3) Symptoms (e.g., cough, shortness of breath) have improved, and (4) Consider consultation with infection control experts. - Patients who were asymptomatic throughout their infection and are not severely immunocompromised: (1) At least 10 days have passed since the date of their first positive viral diagnostic test.

COVID-19 = coronavirus disease 2019, WHO = World Health Organization, CDC = Centers for Disease Control and Prevention, ECDC = European Centre for Disease Prevention and Control, KDCA = Korea Disease Control and Prevention Agency, PPE = personal protective equipment, PCR = polymerase chain reaction, AGP = aerosol-generating procedure. aSymptom-based criteria for discontinuing transmission-based precautions; - Patients with mild to moderate illness who are not severely immunocompromised: (1) At least 10 days have passed since symptoms first appeared, (2) At least 24 hours have passed since last fever without the use of fever-reducing medications, and (3) Symptoms (e.g., cough, shortness of breath) have improved. - Patients with severe to critical illness or who are severely immunocompromised: (1) At least 10 days and up to 20 days have passed since symptoms first appeared, (2) At least 24 hours have passed since last fever without the use of fever-reducing medications, (3) Symptoms (e.g., cough, shortness of breath) have improved, and (4) Consider consultation with infection control experts. - Patients who were asymptomatic throughout their infection and are not severely immunocompromised: (1) At least 10 days have passed since the date of their first positive viral diagnostic test.

Infection control measures for healthcare workers in hospitals

All four organizations recommended an equivalent level of personal protective equipment (PPE) to treat patients suspected or confirmed with COVID-19: N95/high-level respirator, gown, gloves, and eye protector. Only WHO and ECDC recommended using PPE for the disposal of items from patients with confirmed COVID-19. All guidelines did not consistently recommend disinfection or sterilization of N95/KF94 for reuse. CDC and KDCA provided guidance for disinfection or sterilization of powered air-purifying respirator hoods for reuse. No organization provided guidance for separating healthcare workers who participate in the care of patients with COVID-19 from those who care for general patients. There were also no recommendations for regular monitoring with PCR tests or chest X-rays or a limit on working hours to prevent excessive workloads for healthcare workers who treat patients with COVID-19. Daily screening using the COVID-19 checklist was recommended in all guidelines. As for work restriction policies, only CDC provided recommendations for work restriction or PCR tests for healthcare workers who have been in contact with COVID-19 patients or had a fever or respiratory symptoms. The criterion for returning to work for healthcare workers with fever or respiratory symptoms was a single negative PCR test in the CDC guideline. As for the recommendation for activities outside the hospital for healthcare workers, CDC and ECDC provided some guidance, while WHO and KDCA had no guidance (Table 2).
Table 2

Infection control measures for the healthcare workers in the hospital

Controversial issues and subordinate questionsWHOCDCECDCKDCA
PPE for healthcare workers providing care for COVID-19 patients
1. PPE for the treatment of patients confirmed with COVID-19N95/high-level respirator, gown, gloves, eye protectorN95/high-level respirator, gown, gloves, eye protectorN95/high-level respirator, gown, gloves, eye protectorN95/high-level respirator, gown, gloves, eye protector
2. PPE for the treatment of patients suspected or confirmed with COVID-19: aerosol-producing proceduresN95/high-level respirator, gown, gloves, eye protectorN95/high-level respirator, gown, gloves, eye protectorN95/high-level respirator, gown, gloves, eye protectorN95/high-level respirator, gown, gloves, eye protector
3. PPE for the treatment and collection of samples from patients suspected of COVID-19N95/high-level respirator, gown, gloves, eye protectorN95/high-level respirator, gown, gloves, eye protectorN95/high-level respirator, gown, gloves, eye protectorN95/high-level respirator, gown, gloves, eye protector
4. PPE for the treatment of patients requiring hospitalization during self-quarantine periodN95/high-level respirator, gown, gloves, eye protectionN95/high-level respirator, gown, gloves, eye protectionN95/high-level respirator, gown, gloves, eye protectionN95/high-level respirator, gown, gloves, eye protection
5. PPE for the treatment of patients whose symptoms have improved and released from isolation but COVID-19 PCR results are still positiveNot recommendNot recommendNot recommendNot recommend
6. PPE for disposal of items from COVID-19 confirmed patientsMedical mask, gown, heavy duty gloves, eye protector-N95/high-level respirator, gown, gloves, eye protector-
7. Education concerning wearing and removing PPE in the hospitalRecommendRecommendRecommendRecommend
Measures to prevent a shortage of PPE
1. Disinfection or sterilization of N95/KF94 for reuseNot recommendNot recommendReuse as a last resortNot recommend
2. Disinfection or sterilization of PAPR hoods for reuse-Disinfect according to the manufacturer’s reuse guidelines-Disinfect according to the manufacturer’s reuse guidelines
3. Replaceable PPE strategy in the case of shortage of PPE for medical staffUse respirators for an extended timeUse medical masks instead of respiratorsUse medical masks instead of respirators-
4. Other preventive measures for excessive use of PPERecommend telemedicine for mild symptom-patients, use physical barriers to prevent direct contact with patients, minimize number of HCW for treating isolated patients-Minimize the use of PPE in cohort isolation wards if the number of patients exceeds the capacity, perform the procedures at once and minimize contact-
Measures for healthcare workers participating in the care of COVID-19 patients
1. Separate them from the care of general patients----
2. Regular monitoring with PCR tests or CXR----
3. Limit working hours to prevent excessive workloads----
4. Screen with the COVID-19 checklistRecommendRecommendRecommendRecommend
Work restriction Policy for healthcare workers
1. Work restriction and/or performing PCR tests on healthcare workers who have visited high-risk areas of COVID-19 but have no clear epidemiological relations----
2. Work restriction and/or performing PCR tests on healthcare workers who have been in contact with COVID-19 patients prior to confirmation-Recommend both if they did not use proper PPE--
3. Existence of plans for the lack of healthcare workers due to the quarantine within the hospital-Recommend for establishment of plans--
4. Work restriction and/or performing PCR tests on healthcare workers who have fever or respiratory symptoms-Recommend both--
- When to perform PCR test-As soon as symptoms are recognized--
- The conditions for returning to work(Confirmed COVID-19)Single negative PCR result--
10 days after isolation or 3 days after being asymptomatic
- Active surveillance policy after returning to work-Self-monitoring after returning to work, wearing mask--
Recommendation for activities outside the hospital for healthcare workers
1. Existence of restrictions on certain activities outside the hospital-Keep social distancing, avoid visiting high-risk areasKeep social distancing, use own car to commute, use separate room at home if they perform high-risk group care-

COVID-19 = coronavirus disease 2019, WHO = World Health Organization, CDC = Centers for Disease Control and Prevention, ECDC = European Centre for Disease Prevention and Control, KDCA = Korea Disease Control and Prevention Agency, PPE = personal protective equipment, HCW = health care worker, PAPR = powered air-purifying respirator, PCR = polymerase chain reaction, CXR = chest X-ray.

COVID-19 = coronavirus disease 2019, WHO = World Health Organization, CDC = Centers for Disease Control and Prevention, ECDC = European Centre for Disease Prevention and Control, KDCA = Korea Disease Control and Prevention Agency, PPE = personal protective equipment, HCW = health care worker, PAPR = powered air-purifying respirator, PCR = polymerase chain reaction, CXR = chest X-ray.

DISCUSSION

As for the screening and selective treatment policy, there were no guidelines on the criteria for permission to enter a general outpatient clinic. Since the COVID-19 pandemic began, many hospitals have been operating outdoor screening clinics for managing patients with suspected COVID-19 symptoms, such as fever and respiratory symptoms.18 However, screening clinics are equipped with minimal facilities and a workforce that can only provide a minimal examination. Therefore, many hospitals often care for patients with fever and respiratory symptoms who are unlikely to have COVID-19 in the general outpatient clinic because screening clinics have difficulty providing careful evaluation and management. There might be differences among hospitals regarding criteria for permission to enter general outpatient clinics due to the lack of clear guidance on this issue. A single-center study conducted in South Korea found that 350 suspected COVID-19 cases, defined by symptom and epidemiological associations, were preemptively isolated, and none of them were confirmed with COVID-19.19 Based on the result of this study, both WHO and CDC guidelines, which suggested that isolation can be discontinued if there are no symptoms or if the PCR test is negative, seem appropriate. After all, both WHO and CDC guidelines might be used only in the low possibility of confirmation, such as no close contact with COVID-19 patients. CDC recommended PCR tests for screening of COVID-19 even for hospitalized patients without COVID-19-related symptoms. The proportion of asymptomatic patients among COVID-19 cases was about 20–30%, and viral shedding also occurred in such patients; there have been concerns about spreading COVID-19 by asymptomatic patients.202122 According to the Infectious Diseases Society of America, the prevalence of COVID-19 among asymptomatic individuals is < 1 to 10%, and considering results of missing a diagnosis of COVID-19 and the sensitivity of the PCR tests, screening for asymptomatic patients is expected to be effective in regions with more than 2% prevalence.23 A study conducted in long-term care facilities in the United States showed that the prevalence of COVID-19 in facilities that performed broad preemptive PCR tests on inpatients was 0.5%, which was significantly lower than 28.0% in facilities that did not perform them.24 This result supports the effectiveness of PCR screening on asymptomatic inpatients. There were no guidelines for patients who were released from isolation despite a positive PCR test. Although the probability of the existence of infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is very low after 10 days from the onset of COVID-19 symptoms in most cases, patients who are severely ill or immunocompromised could transmit infectious virus particles even after 10 days.2526272829 Therefore, there have been concerns about the possibility of spreading COVID-19 from hospitalized patients who were released from isolation despite a positive PCR test, especially those who need aerosol-generating procedures.28303132 Given that the cut-off values for quantitative RT-PCR and quantitative immunoassays tend to be correlated with infectivity of COVID-19, some researchers have suggested that certain cut-off values could be used as a surrogate marker for the decision to release hospitalized patients from isolation.283334 Further research is needed to determine clear test-based criteria that can guarantee the lack of infectivity of the virus. Regarding strategies for healthcare workers, there were many recommendations on PPE, but few guidelines for the management of healthcare workers. More specific recommendations are required for patients and healthcare workers because outbreaks in medical institutions could also be spread by medical personnel.35 In addition, there are various reports that healthcare workers in charge of managing patients with COVID-19 are complaining of psychological distress and being exposed to the risk of infection; thus, recommendations to prevent burnout are also needed.3637 There were some potential limitations to this study. Recommendations on key topics might have been updated since then. First, guidelines from only four organizations were reviewed due to linguistic limitations. Second, we reviewed WHO, CDC, ECDC, and KDCA guidelines in September 2020. Even though there have been no critical changes of recommendations on key topics, some significant newly introduced recommendations have been found in revised guidelines until November 2021 (Supplementary Table 3). Given that the average incubation period of COVID-19 is 4 to 5 days after exposure to SARS-CoV-2, CDC currently recommends performing a second PCR test to remove preemptive isolation and return to work for the persons with a higher level of suspicion for COVID-19.38 Moreover, since mRNA vaccines against COVID-19 showed significant efficacy, CDC currently suggests preemptive isolation and PCR tests only for unvaccinated patients if they have no symptoms.39 However, as it has been confirmed that the effectiveness of the vaccine decreases over time, further consideration of the validity period of the vaccine is needed.40 In conclusion, the current guidelines are not yet concrete and uniform enough to be applied to hospital settings, and there is a lack of clear guidelines on controversial vital topics that need to be considered in real medical situations. Therefore, it is necessary to develop recommendations that can be applied to hospital settings after an analysis based on clinical experiences and discussion with experts.
  19 in total

1.  Estimating the Latent Period of Coronavirus Disease 2019 (COVID-19).

Authors:  Hualei Xin; Yu Li; Peng Wu; Zhili Li; Eric H Y Lau; Ying Qin; Liping Wang; Benjamin J Cowling; Tim K Tsang; Zhongjie Li
Journal:  Clin Infect Dis       Date:  2022-05-03       Impact factor: 9.079

2.  Work-related COVID-19 transmission in six Asian countries/areas: A follow-up study.

Authors:  Fan-Yun Lan; Chih-Fu Wei; Yu-Tien Hsu; David C Christiani; Stefanos N Kales
Journal:  PLoS One       Date:  2020-05-19       Impact factor: 3.240

3.  Protection and Response of a Tertiary Hospital in South Korea to the COVID-19 Outbreak.

Authors:  Hye Jin Shi; Jae Back Lee; Min Kyung Choi; Young-Rock Jang; Yong-Kyun Cho; Joong Sik Eom
Journal:  Disaster Med Public Health Prep       Date:  2020-06-22       Impact factor: 1.385

4.  Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset.

Authors:  Hao-Yuan Cheng; Shu-Wan Jian; Ding-Ping Liu; Ta-Chou Ng; Wan-Ting Huang; Hsien-Ho Lin
Journal:  JAMA Intern Med       Date:  2020-09-01       Impact factor: 21.873

5.  Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.

Authors:  Melissa M Arons; Kelly M Hatfield; Sujan C Reddy; Anne Kimball; Allison James; Jesica R Jacobs; Joanne Taylor; Kevin Spicer; Ana C Bardossy; Lisa P Oakley; Sukarma Tanwar; Jonathan W Dyal; Josh Harney; Zeshan Chisty; Jeneita M Bell; Mark Methner; Prabasaj Paul; Christina M Carlson; Heather P McLaughlin; Natalie Thornburg; Suxiang Tong; Azaibi Tamin; Ying Tao; Anna Uehara; Jennifer Harcourt; Shauna Clark; Claire Brostrom-Smith; Libby C Page; Meagan Kay; James Lewis; Patty Montgomery; Nimalie D Stone; Thomas A Clark; Margaret A Honein; Jeffrey S Duchin; John A Jernigan
Journal:  N Engl J Med       Date:  2020-04-24       Impact factor: 91.245

6.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

Authors:  Fernando P Polack; Stephen J Thomas; Nicholas Kitchin; Judith Absalon; Alejandra Gurtman; Stephen Lockhart; John L Perez; Gonzalo Pérez Marc; Edson D Moreira; Cristiano Zerbini; Ruth Bailey; Kena A Swanson; Satrajit Roychoudhury; Kenneth Koury; Ping Li; Warren V Kalina; David Cooper; Robert W Frenck; Laura L Hammitt; Özlem Türeci; Haylene Nell; Axel Schaefer; Serhat Ünal; Dina B Tresnan; Susan Mather; Philip R Dormitzer; Uğur Şahin; Kathrin U Jansen; William C Gruber
Journal:  N Engl J Med       Date:  2020-12-10       Impact factor: 91.245

7.  Psychological distress among infectious disease physicians during the response to the COVID-19 outbreak in the Republic of Korea.

Authors:  Se Yoon Park; Bongyoung Kim; Dong Sik Jung; Sook In Jung; Won Sup Oh; Shin-Woo Kim; Kyong Ran Peck; Hyun-Ha Chang
Journal:  BMC Public Health       Date:  2020-11-27       Impact factor: 3.295

Review 8.  The Impact of COVID-19 on Healthcare Worker Wellness: A Scoping Review.

Authors:  Jacob Shreffler; Jessica Petrey; Martin Huecker
Journal:  West J Emerg Med       Date:  2020-08-17

9.  Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis.

Authors:  Diana Buitrago-Garcia; Dianne Egli-Gany; Michel J Counotte; Stefanie Hossmann; Hira Imeri; Aziz Mert Ipekci; Georgia Salanti; Nicola Low
Journal:  PLoS Med       Date:  2020-09-22       Impact factor: 11.069

View more
  2 in total

1.  Perceived Physical and Mental Health and Healthy Eating Habits During the COVID-19 Pandemic in Korea.

Authors:  Yetsa A Tuakli-Wosornu; Uma Pandiyan; Catherine Stratton; Youngdeok Hwang; Abderrazak Hajjioui; Laura Paulina Muñoz-Velasco; Maryam Fourtassi; Rory Cooper; Joseph K Balikuddembe; Mark Peterson; Andrei Krassioukov; Angela Palomba; Deo Rishi Tripathi; Bo Young Hong
Journal:  J Korean Med Sci       Date:  2022-04-18       Impact factor: 5.354

2.  Differences in strategies for prevention of COVID-19 transmission in hospitals: nationwide survey results from the Republic of Korea.

Authors:  W Jang; B Kim; E S Kim; K-H Song; S M Moon; M J Lee; J Y Park; J-Y Kim; M J Shin; H Lee; H B Kim
Journal:  J Hosp Infect       Date:  2022-08-20       Impact factor: 8.944

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.